These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

466 related items for PubMed ID: 19035498

  • 1. Spliceosomal peptide P140 for immunotherapy of systemic lupus erythematosus: results of an early phase II clinical trial.
    Muller S, Monneaux F, Schall N, Rashkov RK, Oparanov BA, Wiesel P, Geiger JM, Zimmer R.
    Arthritis Rheum; 2008 Dec; 58(12):3873-83. PubMed ID: 19035498
    [Abstract] [Full Text] [Related]

  • 2. Longitudinal fluctuation of antibodies to extractable nuclear antigens in systemic lupus erythematosus.
    Faria AC, Barcellos KS, Andrade LE.
    J Rheumatol; 2005 Jul; 32(7):1267-72. PubMed ID: 15996063
    [Abstract] [Full Text] [Related]

  • 3. Prevalence of autoantibodies to ribosomal P proteins in juvenile-onset systemic lupus erythematosus compared with the adult disease.
    Reichlin M, Broyles TF, Hubscher O, James J, Lehman TA, Palermo R, Stafford HA, Taylor-Albert E, Wolfson-Reichlin M.
    Arthritis Rheum; 1999 Jan; 42(1):69-75. PubMed ID: 9920016
    [Abstract] [Full Text] [Related]

  • 4. Efficacy and safety of infliximab in active SLE: a pilot study.
    Uppal SS, Hayat SJ, Raghupathy R.
    Lupus; 2009 Jul; 18(8):690-7. PubMed ID: 19502264
    [Abstract] [Full Text] [Related]

  • 5. Concentration of antibodies to extractable nuclear antigens and disease activity in systemic lupus erythematosus.
    Agarwal S, Harper J, Kiely PD.
    Lupus; 2009 Apr; 18(5):407-12. PubMed ID: 19318392
    [Abstract] [Full Text] [Related]

  • 6. Antibody clustering helps refine lupus prognosis.
    Kessel A, Rosner I, Halasz K, Grushko G, Shoenfeld Y, Paran D, Toubi E.
    Semin Arthritis Rheum; 2009 Aug; 39(1):66-70. PubMed ID: 18538829
    [Abstract] [Full Text] [Related]

  • 7. Anti-nucleosome and anti-chromatin antibodies are present in active systemic lupus erythematosus but not in the cutaneous form of the disease.
    Souza A, da Silva LM, Oliveira FR, Roselino AM, Louzada-Junior P.
    Lupus; 2009 Mar; 18(3):223-9. PubMed ID: 19213860
    [Abstract] [Full Text] [Related]

  • 8. The pathogenetic role of immunoglobulin G from patients with systemic lupus erythematosus in the development of lupus pleuritis.
    Guo H, Leung JC, Chan LY, Chan TM, Lai KN.
    Rheumatology (Oxford); 2004 Mar; 43(3):286-93. PubMed ID: 14623950
    [Abstract] [Full Text] [Related]

  • 9. Autoantibodies to a NR2A peptide of the glutamate/NMDA receptor in sera of patients with systemic lupus erythematosus.
    Husebye ES, Sthoeger ZM, Dayan M, Zinger H, Elbirt D, Levite M, Mozes E.
    Ann Rheum Dis; 2005 Aug; 64(8):1210-3. PubMed ID: 15708887
    [Abstract] [Full Text] [Related]

  • 10. Naturally occurring V region connected antibodies inhibit anti-dsDNA antibody reactivity with dsDNA.
    Srdic-Rajic T, Jurisic V, Andrejevic S, Bonaci-Nikolic B, Bowker T, Concas D, Metlas R.
    Immunobiology; 2012 Jan; 217(1):111-7. PubMed ID: 21840618
    [Abstract] [Full Text] [Related]

  • 11. B cell depletion therapy in systemic lupus erythematosus: relationships among serum B lymphocyte stimulator levels, autoantibody profile and clinical response.
    Cambridge G, Isenberg DA, Edwards JC, Leandro MJ, Migone TS, Teodorescu M, Stohl W.
    Ann Rheum Dis; 2008 Jul; 67(7):1011-6. PubMed ID: 17962238
    [Abstract] [Full Text] [Related]

  • 12. Cross-reactivity of human lupus anti-DNA antibodies with alpha-actinin and nephritogenic potential.
    Zhao Z, Weinstein E, Tuzova M, Davidson A, Mundel P, Marambio P, Putterman C.
    Arthritis Rheum; 2005 Feb; 52(2):522-30. PubMed ID: 15693007
    [Abstract] [Full Text] [Related]

  • 13. Estrogen enhancement of anti-double-stranded DNA antibody and immunoglobulin G production in peripheral blood mononuclear cells from patients with systemic lupus erythematosus.
    Kanda N, Tsuchida T, Tamaki K.
    Arthritis Rheum; 1999 Feb; 42(2):328-37. PubMed ID: 10025928
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Association of antinucleosome antibodies with disease flare in serologically active clinically quiescent patients with systemic lupus erythematosus.
    Ng KP, Manson JJ, Rahman A, Isenberg DA.
    Arthritis Rheum; 2006 Dec 15; 55(6):900-4. PubMed ID: 17139667
    [Abstract] [Full Text] [Related]

  • 18. Umbilical cord mesenchymal stem cell transplantation in severe and refractory systemic lupus erythematosus.
    Sun L, Wang D, Liang J, Zhang H, Feng X, Wang H, Hua B, Liu B, Ye S, Hu X, Xu W, Zeng X, Hou Y, Gilkeson GS, Silver RM, Lu L, Shi S.
    Arthritis Rheum; 2010 Aug 15; 62(8):2467-75. PubMed ID: 20506343
    [Abstract] [Full Text] [Related]

  • 19. Increased levels of serum protein oxidation and correlation with disease activity in systemic lupus erythematosus.
    Morgan PE, Sturgess AD, Davies MJ.
    Arthritis Rheum; 2005 Jul 15; 52(7):2069-79. PubMed ID: 15986354
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.